[Results of the treatment of patients with advanced lung cancer with the combination of methotrexate, adriamycin, cyclophosphamide and CCNU (MACC)].
Lisowska
B
B
Krawczyk
K
K
Krochmal
M
M
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging
D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
Wyniki leczenia chorych na zaawansowanego raka płuca skojarzeniem metotreksatu, adriamycyny, cyklofosfamidu i CCNU/MACC.